[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE107278T1 - Enantioselektives verfahren zur herstellung von 1-beta-methylcarbapenem- antibiotikumzwischenprodukten. - Google Patents

Enantioselektives verfahren zur herstellung von 1-beta-methylcarbapenem- antibiotikumzwischenprodukten.

Info

Publication number
ATE107278T1
ATE107278T1 AT86104146T AT86104146T ATE107278T1 AT E107278 T1 ATE107278 T1 AT E107278T1 AT 86104146 T AT86104146 T AT 86104146T AT 86104146 T AT86104146 T AT 86104146T AT E107278 T1 ATE107278 T1 AT E107278T1
Authority
AT
Austria
Prior art keywords
compound
alkyl
chem
beta
preparation
Prior art date
Application number
AT86104146T
Other languages
English (en)
Inventor
Ichiro Shinkai
Thomas N Salzmann
Lelia M Fuentes
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE107278T1 publication Critical patent/ATE107278T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/26Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT86104146T 1985-03-29 1986-03-26 Enantioselektives verfahren zur herstellung von 1-beta-methylcarbapenem- antibiotikumzwischenprodukten. ATE107278T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71774285A 1985-03-29 1985-03-29
US71734285A 1985-03-29 1985-03-29
US71774685A 1985-03-29 1985-03-29

Publications (1)

Publication Number Publication Date
ATE107278T1 true ATE107278T1 (de) 1994-07-15

Family

ID=27418970

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86104146T ATE107278T1 (de) 1985-03-29 1986-03-26 Enantioselektives verfahren zur herstellung von 1-beta-methylcarbapenem- antibiotikumzwischenprodukten.

Country Status (8)

Country Link
EP (1) EP0197432B1 (de)
JP (2) JPH05320159A (de)
AT (1) ATE107278T1 (de)
CA (3) CA1276156C (de)
DE (1) DE3689911D1 (de)
DK (1) DK141786A (de)
ES (1) ES8800215A1 (de)
IE (1) IE860840L (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE109764T1 (de) * 1985-12-28 1994-08-15 Sumitomo Pharma Beta-lactamverbindungen und deren herstellung.
US5231179A (en) * 1986-01-27 1993-07-27 Sumitomo Pharmaceuticals Company, Limited Heterocyclic compounds and their production
JP2789190B2 (ja) * 1986-01-27 1998-08-20 住友製薬株式会社 新規なβ−ラクタム誘導体およびその製造法
GB8607921D0 (en) * 1986-04-01 1986-05-08 Fujisawa Pharmaceutical Co 3,4-disubstituted-2-azetidinone derivatives
EP0241200B1 (de) * 1986-04-07 1990-12-27 Merck & Co. Inc. Verfahren zur Herstellung von 1-Betamethylcarbapenem-Antibiotikum-Zwischenprodukten
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
DE69405922T2 (de) * 1993-06-30 1998-01-29 Nippon Soda Co Verfahren zur Herstellung von 4-substituierten Azetidinon-Derivaten
JP3450193B2 (ja) * 1998-07-24 2003-09-22 高砂香料工業株式会社 4−置換アゼチジノン誘導体の製造方法
CN113817299B (zh) * 2021-08-18 2022-12-13 安徽建筑大学 一种具有离子和化学双重交联结构的pla基共混复合材料及其制备方法
CN113970500B (zh) * 2021-10-27 2023-08-29 北京新风航天装备有限公司 一种油污固废含油率快速测定方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2399118A (en) 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
US3950357A (en) 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4383946A (en) 1980-03-27 1983-05-17 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via silyl-substituted dithioacetals
ES8404184A1 (es) * 1981-08-03 1984-04-16 Merck & Co Inc Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
JPS6019763A (ja) 1983-07-13 1985-01-31 Sankyo Co Ltd アゼチジノンチオエステル類の製造法

Also Published As

Publication number Publication date
CA1319697C (en) 1993-06-29
EP0197432B1 (de) 1994-06-15
JPH05320171A (ja) 1993-12-03
DK141786A (da) 1986-09-30
ES8800215A1 (es) 1987-10-16
DE3689911D1 (de) 1994-07-21
ES553461A0 (es) 1987-10-16
JPH05320159A (ja) 1993-12-03
EP0197432A2 (de) 1986-10-15
CA1276156C (en) 1990-11-13
CA1279649C (en) 1991-01-29
EP0197432A3 (en) 1987-01-21
DK141786D0 (da) 1986-03-26
IE860840L (en) 1986-09-29

Similar Documents

Publication Publication Date Title
ATE107278T1 (de) Enantioselektives verfahren zur herstellung von 1-beta-methylcarbapenem- antibiotikumzwischenprodukten.
ATE66474T1 (de) Verfahren zur herstellung von substituierten 3chinolincarbonsaeuren.
DE69102462D1 (de) Verfahren zur Herstellung von 1,5-Benzothiazepin-Derivaten.
ATE10735T1 (de) Verfahren zur herstellung von chinonderivaten.
ATE98696T1 (de) Verfahren zur herstellung von peroxykarbonsaeuren unter verwendung eines enzymkatalysators.
DE69937988D1 (de) Verfahren zur herstellung von 3-cephemderivaten
KR850005838A (ko) 1,3,2-디옥사보리난의 제조방법
ATE61329T1 (de) Verfahren zur herstellung von rooperol, hypoxosid und deren derivaten.
PT87901A (pt) Processo para a preparacao de acidos 2-ariloxipropionicos e de composicoes herbicidas contendo estes compostos
DE3777325D1 (de) 2-amino-4-phosphonyl-buttersaeurederivate und herstellung von 2-amino-4-phosphinyl-butter-saeuren.
ATE38980T1 (de) Verfahren zur herstellung von l-carnitin.
ES2067468T3 (es) Secuencia de reaccion de adicion en 1,2-1,4 para dar difenilacetilenos.
ATE25680T1 (de) Verfahren zur herstellung von 4-amino-5-dialkoxy- methylpyrimidinderivaten.
DE69024114D1 (de) Verfahren zur Herstellung von Penemen
ATE18208T1 (de) N-(4-hydroxyphenyl)essigsaeureamid-estern aus 5benzoyl-1-methylpyrrol-2-essigsaeure.
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.
ATE58376T1 (de) Verfahren zur herstellung von azetidinon-1oxoessigs|ureesterdurch oxydation des uebereinstimmenden 2-hydroxyessigsaeureesters.
DE3772703D1 (de) Verfahren zur herstellung von penemen.
ATE75715T1 (de) Verfahren zur herstellung von 6-hydroxy-2naphtonen.
ATE24507T1 (de) Verfahren zur herstellung von lysergsaeure-estern.
ATE967T1 (de) Verfahren zur herstellung von xanthonderivaten.
ATE57934T1 (de) Verfahren zur herstellung von griseolinsaeurederivaten.
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE64381T1 (de) Verfahren zur herstellung von betalactamderivaten.
ATE75491T1 (de) Verfahren zur modifizierung von polyfumarsaeurediestern.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties